Literature DB >> 18082393

In pursuit of a super producer-alternative paths to high producing recombinant mammalian cells.

Gargi Seth1, Salim Charaniya, Katie F Wlaschin, Wei-Shou Hu.   

Abstract

Recombinant mammalian cells are used to produce numerous, high-value protein therapeutics. Generating hyper-producing cell lines is crucial for delivery of products to ailing patients. Better understanding of the complex trait of hyperproductivity can facilitate the creation of hyper-producing cell lines. Ruminating over the reported transcriptomic and proteomic studies, we attempt to assess whether high productivity response is a result of minute changes occurring globally or large alterations observed locally at the molecular level. We present here our philosophical perspective on the alternative routes to high productivity. We contend that given the advances in genome-scale technologies and data analysis approaches, insights gained from elucidating the gene-trait relationship underlying hyperproductivity will accelerate the development of hyperproductive processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082393     DOI: 10.1016/j.copbio.2007.10.012

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  11 in total

Review 1.  A review of the mammalian unfolded protein response.

Authors:  Anirikh Chakrabarti; Aaron W Chen; Jeffrey D Varner
Journal:  Biotechnol Bioeng       Date:  2011-08-09       Impact factor: 4.530

2.  Generation and screening of Pichia pastoris strains with enhanced protein production by use of microengraving.

Authors:  Vasiliki Panagiotou; Kerry Routenberg Love; Bo Jiang; Juergen Nett; Terrance Stadheim; J Christopher Love
Journal:  Appl Environ Microbiol       Date:  2011-03-04       Impact factor: 4.792

Review 3.  Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics.

Authors:  Arpan A Bandyopadhyay; Anurag Khetan; Li-Hong Malmberg; Weichang Zhou; Wei-Shou Hu
Journal:  J Ind Microbiol Biotechnol       Date:  2017-02-09       Impact factor: 3.346

4.  Early integration of Design of Experiment (DOE) and multivariate statistics identifies feeding regimens suitable for CHO cell line development and screening.

Authors:  Alessandro Mora; Bernard Nabiswa; Yuanyuan Duan; Sheng Zhang; Gerald Carson; Seongkyu Yoon
Journal:  Cytotechnology       Date:  2019-11-09       Impact factor: 2.058

5.  Single Copy Transgene Integration in a Transcriptionally Active Site for Recombinant Protein Synthesis.

Authors:  Sofie A O'Brien; Kyoungho Lee; Hsu-Yuan Fu; Zion Lee; Tung S Le; Christopher S Stach; Meghan G McCann; Alicia Q Zhang; Michael J Smanski; Nikunj V Somia; Wei-Shou Hu
Journal:  Biotechnol J       Date:  2018-07-30       Impact factor: 4.677

6.  Development of Genetically Modified Chinese Hamster Ovary Host Cells for the Enhancement of Recombinant Tissue Plasminogen Activator Expression.

Authors:  Azam Rahimpour; Roshanak Ahani; Azita Najaei; Ahmad Adeli; Farzaneh Barkhordari; Fereidoun Mahboudi
Journal:  Malays J Med Sci       Date:  2016-03

7.  The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line.

Authors:  Xun Xu; Harish Nagarajan; Nathan E Lewis; Shengkai Pan; Zhiming Cai; Xin Liu; Wenbin Chen; Min Xie; Wenliang Wang; Stephanie Hammond; Mikael R Andersen; Norma Neff; Benedetto Passarelli; Winston Koh; H Christina Fan; Jianbin Wang; Yaoting Gui; Kelvin H Lee; Michael J Betenbaugh; Stephen R Quake; Iman Famili; Bernhard O Palsson; Jun Wang
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

8.  Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype.

Authors:  Paula Meleady; Padraig Doolan; Michael Henry; Niall Barron; Joanne Keenan; Finbar O'Sullivan; Colin Clarke; Patrick Gammell; Mark W Melville; Mark Leonard; Martin Clynes
Journal:  BMC Biotechnol       Date:  2011-07-24       Impact factor: 2.563

9.  The relationship between mTOR signalling pathway and recombinant antibody productivity in CHO cell lines.

Authors:  Raihana Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2014-02-17       Impact factor: 2.563

10.  Combination of FACS and homologous recombination for the generation of stable and high-expression engineered cell lines.

Authors:  Lei Shi; Xuesi Chen; Wenying Tang; Zhenyi Li; Jin Liu; Feng Gao; Jianli Sang
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.